BioCryst Pharmaceuticals Inc Strategic Asset Allocation Index
BioCryst Pharmaceuticals Inc strategic asset allocation index. BioCryst Pharmaceuticals Inc (BCRX) has a Strategic Asset Allocation Index of 30.2% as of September 2020. Strategic assets (PP&E of $7.14 Million plus long-term investments of $3.00 Million) total $10.14 Million, measured against net assets of $33.64 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check BCRX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of BioCryst Pharmaceuticals Inc (2000–2019)
Strategic asset allocation index of BioCryst Pharmaceuticals Inc from 2000 to 2019. This chart shows how BioCryst Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2000 to 2019. As of September 2020, the index stands at 30.2%, representing strategic assets of $10.14 Million against net assets of $33.64 Million USD.
BioCryst Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2000–2019)
BioCryst Pharmaceuticals Inc strategic asset allocation index by year from 2000 to 2019. The table below presents the year-by-year Strategic Asset Allocation Index for BioCryst Pharmaceuticals Inc from 2000 to 2019, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BCRX stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 19.2% | $7.35 Million | $7.35 Million | $0.00 | $38.25 Million | ▼ -44.8 pp |
| 2018 | 64.0% | $31.51 Million | $9.13 Million | $22.38 Million | $49.23 Million | ▲ +3.3 pp |
| 2017 | 60.7% | $50.84 Million | $9.55 Million | $41.30 Million | $83.77 Million | ▼ -1133.7 pp |
| 2016 | 1194.4% | $18.85 Million | $9.92 Million | $8.93 Million | $1.58 Million | ▲ +1083.7 pp |
| 2015 | 110.7% | $52.83 Million | $5.15 Million | $47.68 Million | $47.72 Million | ▲ +56.1 pp |
| 2014 | 54.6% | $41.32 Million | $207.00K | $41.12 Million | $75.64 Million | ▼ -56.7 pp |
| 2011 | 111.3% | $16.48 Million | $1.10 Million | $15.38 Million | $14.81 Million | ▲ +108.4 pp |
| 2010 | 2.9% | $1.93 Million | $1.93 Million | $- | $66.62 Million | ▼ -1.6 pp |
| 2009 | 4.5% | $3.87 Million | $3.87 Million | $- | $86.27 Million | ▼ -6.0 pp |
| 2008 | 10.5% | $4.88 Million | $4.88 Million | $- | $46.43 Million | ▲ +2.4 pp |
| 2007 | 8.2% | $5.29 Million | $5.29 Million | $- | $64.91 Million | ▼ -6.2 pp |
| 2006 | 14.3% | $3.03 Million | $3.03 Million | $- | $21.16 Million | ▲ +10.2 pp |
| 2005 | 4.1% | $2.41 Million | $2.41 Million | $- | $58.44 Million | ▼ -5.5 pp |
| 2004 | 9.6% | $2.82 Million | $2.82 Million | $- | $29.33 Million | ▼ -2.7 pp |
| 2003 | 12.3% | $3.51 Million | $3.51 Million | $- | $28.45 Million | ▲ +1.0 pp |
| 2002 | 11.4% | $4.56 Million | $4.56 Million | $- | $40.13 Million | ▲ +1.9 pp |
| 2001 | 9.5% | $5.40 Million | $5.40 Million | $- | $56.81 Million | ▲ +3.3 pp |
| 2000 | 6.2% | $3.84 Million | $3.84 Million | $- | $61.48 Million | — |